Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 2013 Jul 1;123(7):3182. doi: 10.1172/JCI70645

Host immunity contributes to the anti-melanoma activity of BRAF inhibitors

Deborah A Knight, Shin Foong Ngiow, Ming Li, Tiffany Parmenter, Stephen Mok, Ashley Cass, Nicole M Haynes, Kathryn Kinross, Hideo Yagita, Richard C Koya, Thomas G Graeber, Antoni Ribas, Grant A McArthur, Mark J Smyth
PMCID: PMC3696574

Original citation: J. Clin. Invest. 2013;123(3):1371–1381. doi:10.1172/JCI66236.

Citation for this erratum: J. Clin. Invest. 2013;123(7):3182. doi:10.1172/JCI70645.

During preparation of the manuscript, Figure 9 was labeled incorrectly. The correct figure is below.

Figure 9.

Figure 9

The JCI regrets the error.


Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES